EP3302549
COMBINATION THERAPY OF AN ANTI CD20 ANTIBODY WITH A BCL-2 INHIBITOR AND A MDM2 INHIBITOR
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
23.5.2016EP published:
3.7.2019EP application number:
16725104.0
EPO information:
European Patent Register
Max expiry date:
22.5.2036
Title:
COMBINATION THERAPY OF AN ANTI CD20 ANTIBODY WITH A BCL-2 INHIBITOR AND A MDM2 INHIBITOR
Timeline
Today
23.5.2016EP application
3.7.2019EP Publication
Owner
Name:
F. Hoffmann-La Roche AGAddress:
Grenzacherstrasse 124, 4070, Basel, CH
Inventor
Name:
KLEIN, ChristianAddress:
Bonstetten, CH
Name:
HERTING, FrankAddress:
Penzberg, DE
Name:
DANGL, MarkusAddress:
Seeshaupt, DE
Priority
Number:
15169199Date:
26.5.2015Country:
EP
Classification
Categories:
A61K 39/395, A61K 31/496, A61K 31/40, A61P 35/02, C07K 16/28